Literature DB >> 24877650

Short-term obesity results in detrimental metabolic and cardiovascular changes that may not be reversed with weight loss in an obese dog model.

Jennifer L Adolphe1, Tawni I Silver1, Helene Childs1, Murray D Drew2, Lynn P Weber1.   

Abstract

The time course of metabolic and cardiovascular changes with weight gain and subsequent weight loss has not been elucidated. The goal of the present study was to determine how weight gain, weight loss and altered body fat distribution affected metabolic and cardiovascular changes in an obese dog model. Testing was performed when the dogs were lean (scores 4-5 on a nine-point scale), after ad libitum feeding for 12 and 32 weeks to promote obesity (>5 score), and after weight loss. Measurements included serum glucose and insulin, plasma leptin, adiponectin and C-reactive protein, echocardiography, flow-mediated dilation and blood pressure. Body fat distribution was assessed by computed tomography. Fasting serum glucose concentrations increased significantly with obesity (P< 0·05). Heart rate increased by 22 (SE 5) bpm after 12 weeks of obesity (P= 0·003). Systolic left ventricular free wall thickness increased after 12 weeks of obesity (P= 0·002), but decreased after weight loss compared with that observed in the lean phase (P= 0·03). Ventricular free wall thickness was more strongly correlated with visceral fat (r 0·6, P= 0·001) than with total body fat (r 0·4, P= 0·03) and was not significantly correlated with subcutaneous body fat (r 0·3, P= 0·1). The present study provides evidence that metabolic and cardiovascular alterations occur within only 12 weeks of obesity in an obese dog model and are strongly predicted by visceral fat. These results emphasise the importance of obesity prevention, as weight loss did not result in the return of all metabolic indicators to their normal levels. Moreover, systolic cardiac muscle thickness was reduced after weight loss compared with the pre-obesity levels, suggesting possible acute adverse cardiovascular effects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24877650     DOI: 10.1017/S0007114514001214

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

Review 1.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

Review 2.  Comparative occurrence of diabetes in canine, feline, and few wild animals and their association with pancreatic diseases and ketoacidosis with therapeutic approach.

Authors:  Kamal Niaz; Faheem Maqbool; Fazlullah Khan; Fatima Ismail Hassan; Saeideh Momtaz; Mohammad Abdollahi
Journal:  Vet World       Date:  2018-04-05

3.  Evaluation of visceral fat mass in dogs by computed tomography.

Authors:  Itsuma Nagao; Koichi Ohno; Takuro Nagahara; Nozomu Yokoyama; Taisuke Nakagawa; Reina Fujiwara; Kie Yamamoto; Yuko Goto-Koshino; Hirotaka Tomiyasu; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2019-09-25       Impact factor: 1.267

4.  A Systematic Review and Meta-Analysis of Serum Adiponectin Measurements in the Framework of Dog Obesity.

Authors:  Alberto Muñoz-Prieto; José Joaquín Cerón; Silvia Martínez-Subiela; Vladimir Mrljak; Asta Tvarijonaviciute
Journal:  Animals (Basel)       Date:  2020-09-14       Impact factor: 2.752

5.  The effect of obesity and subsequent weight reduction on cardiac structure and function in dogs.

Authors:  C Partington; H Hodgkiss-Geere; G R T Woods; J Dukes-McEwan; J Flanagan; V Biourge; A J German
Journal:  BMC Vet Res       Date:  2022-09-20       Impact factor: 2.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.